| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.359 | 23.940 | 81.467 | 135.295 | 168.628 | 138.057 | 87.061 | 204.603 | 146.225 | 78.654 |
| Total Income - EUR | 3.510 | 24.563 | 81.496 | 135.307 | 168.628 | 141.019 | 87.061 | 204.603 | 146.225 | 78.654 |
| Total Expenses - EUR | 10.228 | 45.377 | 80.180 | 84.010 | 107.499 | 99.859 | 109.012 | 96.358 | 134.228 | 119.062 |
| Gross Profit/Loss - EUR | -6.718 | -20.814 | 1.317 | 51.297 | 61.128 | 41.160 | -21.951 | 108.246 | 11.996 | -40.407 |
| Net Profit/Loss - EUR | -6.823 | -21.059 | 507 | 49.944 | 59.442 | 39.920 | -22.450 | 106.200 | 10.518 | -42.767 |
| Employees | 1 | 2 | 2 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Cortex Implants S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 39.172 | 44.591 | 51.112 | 67.044 | 61.355 | 51.717 | 40.475 | 88.523 | 70.454 | 61.074 |
| Current Assets | 9.723 | 3.346 | 13.467 | 2.884 | 37.529 | 45.974 | 29.355 | 36.313 | 52.468 | 34.260 |
| Inventories | 9.254 | 3.097 | 13.169 | 0 | 1.249 | 4.153 | 3.461 | 428 | 18.123 | 23.245 |
| Receivables | 0 | 0 | 0 | 1.431 | 232 | 659 | 666 | 10.867 | 277 | 728 |
| Cash | 469 | 249 | 298 | 1.453 | 36.047 | 41.162 | 25.228 | 25.018 | 34.068 | 10.288 |
| Shareholders Funds | -6.778 | -27.769 | -26.792 | 23.644 | 82.628 | 77.458 | 53.290 | 106.240 | 105.848 | 63.685 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 55.673 | 75.706 | 91.371 | 46.285 | 16.256 | 20.232 | 16.540 | 18.596 | 17.075 | 31.649 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Cortex Implants S.r.l.